• Alert: FDA warns consumers not to use expired Amazon Basic Care Levonorgestrel 1.5 mg
• FDA approves two separate indications for fam-trastuzumab deruxtecan-nxki in HER2-positive early-stage breast cancer
• FDA approves first interchangeable biosimilars to Simponi and Simponi Aria (golimumab) to treat rheumatoid arthritis and ulcerative colitis
• Public Notification: Sâm Xương Khớp Ông Tiên may be harmful due to hidden drug ingredients
• FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular residual disease